Does California Medicaid cover Wegovy and Zepbound in 2026?
No, not since Jan 1, 2026. As of Oct 23, 2026, California Medicaid no longer covers GLP-1 drugs for obesity alone.
Coverage ended in 2026 Checked Oct 23, 2026 Coverage ended Jan 1, 2026
Coverage of GLP-1 drugs for obesity alone under California’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.
California’s rule
In plain words
Coverage ended in 2026
Weight-loss use no longer covered from Jan 1, 2026; other FDA-approved uses continue.
Source
DHCS Medi-Cal Rx alert, Oct 21, 2025 (opens in new tab). Checked Oct 23, 2026.
Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).
What changed
- Jan 1, 2026: Medi-Cal Rx stopped covering GLP-1s used for weight loss. DHCS Medi-Cal Rx alert, Oct 21, 2025 (opens in new tab)
Next steps
Questions this page answers
Does California Medicaid cover Wegovy and Zepbound for weight loss?
No, not since Jan 1, 2026. As of Oct 23, 2026, California Medicaid no longer covers GLP-1 drugs for obesity alone. Weight-loss use no longer covered from Jan 1, 2026; other FDA-approved uses continue.
Has California’s rule changed recently?
Jan 1, 2026: Medi-Cal Rx stopped covering GLP-1s used for weight loss.
Where does this information come from?
From DHCS Medi-Cal Rx alert, Oct 21, 2025, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.
Kymata Health reads each state’s own Medicaid documents. See every state on the map.